Auxly Reports 2025 First Quarter Results
Financial highlights for the first quarter ended March 31, 2025:
Net revenues of $32.7 million, an increase of 29% compared to the same period in 2024.
Gross Margin on Finished Cannabis Inventory Sold 1 of 48%, an increase of 1,000 bps or 26%, compared to the same period in 2024.
SG&A of $9.7 million, an increase of 12% compared to the same period in 2024.
Adjusted EBITDA 1 of $7.4 million, or 23% of net revenue, an increase of 232% compared to the same period in 2024.
Cash flow from operations of $2.0 million and cash at quarter end totalled $17.1 million.
Reduced debt 1 by another 5% from the end of 2024.
Commercial highlights for the first quarter ended March 31, 2025:
#4 largest Canadian Licensed Producer with market share of 5.8% at quarter end 2.
Back Forty exited the quarter as the #1 cannabis brand in Canada.
Launched new cultivar Chemzilla in Ontario which rose to become the #1 SKU in the 14g flower category, reinforcing the strength of the Back Forty brand.
Maintained a leadership position in the competitive vapour category, holding ten of the top fifteen all-in-one SKU positions nationally.
Back Forty remained the #1 non-infused pre-roll brand in Ontario, supported by the launch of high THC cultivars Lemon Diesel and Pine Tar Kush.
Management Commentary
Hugo Alves, CEO of Auxly, commented: "We are pleased to report another exceptional quarter of financial and commercial performance, highlighted by a 29% year-over-year increase in net revenue, and a 232% improvement in adjusted EBITDA. These results reflect the successful execution of our strategy and our focus on teamwork, innovation, and operational efficiency. We continued to see strong growth in distribution, driven in particular by the expanding reach of our flower portfolio. As we continue to strengthen our balance sheet and reduce debt, we are building a solid foundation for long-term leadership and sustainable growth. The future of Auxly is bright and we're just getting started."
Financial Highlights and Key Performance Indicators
For the three months ended:
March 31,
March 31,
(000's)
2025
2024
Change
% Change
Net revenues
$ 32,669
$ 25,241
$ 7,428
29 %
Gross margin on finished cannabis inventory sold*
15,831
9,569
6,262
65 %
Gross margin on finished cannabis inventory sold (%)*
48 %
38 %
10 %
26 %
Net income/(loss)
12,111
(26,012)
38,123
147 %
Adjusted EBITDA*
7,433
2,240
5,193
232 %
Weighted average shares outstanding
1,310,291,543
1,016,839,478
293,452,065
29 %
As at:
March 31,
December 31,
(000's)
2025
2024
Change
% Change
Cash and equivalents
$ 17,112
$ 18,356
$ (1,244)
-7 %
Total assets
264,820
261,530
3,290
1 %
Debt*
52,091
55,683
(2,592)
-5 %
*Non-IFRS or supplementary financial measure. Refer to the Non-GAAP Measures section in the MD&A for definitions.
Results of Operations
(000's)
Three months ended:
March 31, 2025
March 31, 2024
Revenues
Revenue from sales of cannabis products
$ 49,212
$ 38,357
Excise taxes
(16,543)
(13,116)
Total Net Revenues
32,669
25,241
Cost of Sales
Costs of finished cannabis inventory sold
16,838
15,672
Inventory impairment
123
456
Gross profit/(loss) excluding fair value items
15,708
9,113
Unrealized fair value gain/(loss) on biological transformation
12,312
2,773
Realized fair value gain/(loss) on inventory
(9,337)
(2,435)
Gross profit
18,683
9,451
Expenses
Selling, general, and administrative expenses
9,672
8,621
Equity-based compensation
1,505
1,927
Depreciation and amortization
1,296
1,230
Interest and accretion expense
2,147
6,868
Total expenses
14,620
18,646
Other incomes/(loss)
Interest and other income
47
19
Gain/(loss) on settlement of assets and liabilities and other expenses
39
(634)
Foreign exchange gain/(loss)
(163)
(210)
Total other income/(loss)
(77)
(825)
Net income/(loss) before income tax
3,986
(10,020)
Income tax recovery/(expense)
8,125
(15,992)
Net income/(loss)
$ 12,111
$(26,012)
Adjusted EBITDA
$ 7,433
$ 2,240
Net income/(loss) per common share – basic and diluted ($)
$ 0.01
$ (0.03)
Weighted average shares outstanding – basic
1,310,291,543
1,016,839,478
Weighted average shares outstanding – diluted
1,365,880,272
1,016,839,478
Net Revenues
For the three months ended March 31, 2025, net revenues were $32.7 million as compared to $25.2 million during the same period in 2024, representing increases of 29%. Revenues for the three months ended March 31, 2025 were comprised of approximately 63% (2024 – 59%) in sales of dried flower and pre-roll Cannabis Products, with the remainder from oils and Cannabis 2.0 Product sales.
During the first quarter of 2025, approximately 75% (2024 – 76%) of cannabis sales originated from sales to British Columbia, Alberta and Ontario. Since 2024, the Company had sales in all Canadian provinces and the Yukon and Northwest Territories.
Gross Profit
Auxly realized a gross profit of $18.7 million for the three months ended March 31, 2025, resulting in a 57% Gross Profit Margin as compared to $9.5 million or 37% during the same periods in 2024. The Gross Margin on Finished Cannabis Inventory Sold for the three months ended March 31, 2025 improved to 48% versus 38% in 2024 as a result of the streamlining and improvements made in our manufacturing process to reduce operating costs and increased demand and pricing of adult-use recreational market and bulk flower products. Higher cultivation yields lowered costs, and efficiency improvements at our Auxly Charlottetown facility further reduced costs.
Realized and unrealized fair value gains and losses reflect accounting treatments associated with Auxly Leamington cultivation activities and sales and are influenced by changes in production, sales and net realizable value assumptions.
Inventory impairments during the first quarter of 2025 of $0.1 million were associated with charges related to reductions in net realizable value of dried cannabis under the Company's product specifications, a decrease of $0.3 million from the comparative period.
Total Expenses
Selling, general and administrative expenses ("SG&A") are comprised of wages and benefits, office and administrative, professional fees, business development, and selling expenses. SG&A expenses were $9.7 million in the first quarter of 2025, $1.1 million or 12% higher than the same period in 2024. The increase in SG&A was primarily driven by investments to support higher sales.
Wages and benefits were $4.7 million for the quarter, as compared to $4.3 million during the same period in 2024. Wages and benefits increased compared to 2024 due to an increase in bonus accruals which was partially offset by cost savings from the streamlining of operations and support staff as a result of a more focused product portfolio.
Office and administrative expenses were $1.6 million for the quarter, $0.2 million higher than the same period in 2024. The Company continues to actively control overhead spend in the organization while growing sales.
Auxly's professional fees were $0.3 million during the first quarter of 2025, $0.2 million lower than 2024. Professional fees incurred primarily related to accounting fees, regulatory matters, reporting issuer fees, and legal fees associated with certain corporate activities and as a result can fluctuate significantly from one period to the next.
Business development expenses were $nil for three months ended March 31, 2025 as compared to $0.1 million for the same period in 2024. These expenses primarily relate to business development and travel related expenses.
Selling expenses were $3.1 million for the three months ended March 31, 2025, an increase of $0.7 million from the same periods in 2024. The increase in expenditures was primarily as a result of investments in marketing initiatives and higher Health Canada fees related to higher revenues.
Equity-based compensation for the quarter was $1.5 million, primarily driven by the Cash Settled RSUs granted in 2023 and RSUs issued in 2024. During the same period in 2024, equity-based compensation was $1.9 million.
Depreciation and amortization expenses were $1.3 million for the three months ended March 31, 2025, representing an increase of $0.1 million over the same period in 2024 as a result of capital investments made during 2024.
Interest expenses were $2.2 million for the three months ended March 31, 2025, a decrease of $4.7 million over the same period in 2024. The decrease in expenses were primarily a result of the conversion of Imperial Debentures into Shares and lower interest expense on adjustable-rate debt. Interest expense includes accretion on the convertible debentures and interest paid in kind on the Imperial Debenture. Interest payable in cash was approximately $1.8 million for the first quarter of 2025, $0.5 million lower than the same period in 2024 as a result of lower principal amounts outstanding on debt instruments.
Total Other Incomes and Losses
Total other incomes and losses was a net loss of $0.1 million for the three months ended March 31, 2025, compared to a net loss of $0.8 million in the same period in 2024. The other incomes and losses in the first quarter of 2025 were primarily driven by foreign exchange losses. The other incomes and losses in the first quarter of 2024 were primarily driven by the loss on the adjustment to the provision related to the claim filed by Kindred Partners Inc. and foreign exchange losses.
Net Income and Loss
Net income for the three months ended March 31, 2025 was $12.1 million, representing a net income of $0.01 per share on a basic and diluted basis. The net income of $12.1 million in 2025 includes $8.1 million of deferred tax recovery related to the change in estimated useful life of intangible assets. The net loss of $26.0 million for the three months ended March 31, 2024 included $16.0 million of deferred tax expense on the conversion of Imperial Debenture into Shares. Excluding the deferred tax recovery related to the change in estimated useful life of intangible assets in 2025 and the deferred tax expense on the conversion of Imperial Debenture into Shares in 2024, net income increased by $14.0 million primarily due to improved gross profits and reduction in interest and accretion expenses.
Adjusted EBITDA
Adjusted EBITDA was $7.4 million for the quarter, an improvement of $5.2 million when compared to $2.2 million during the same period in 2024. Adjusted EBITDA for the three months ended March 31, 2025 improved primarily as a result of improved gross profits.
Outlook
The Company remains focused on achieving long-term, profitable growth by strengthening its leadership position in the Canadian cannabis market. Auxly consistently develops and commercializes products that resonate with Canadian consumers under trusted brands known for quality and consistency and will continue to execute against its strategy of focused innovation, enhanced product distribution, operational efficiency, and debt reduction.
In the quarter, the Company reported net revenues of $32.7 million, a 29% increase year-over-year, driven by strong performance across key product categories. Liquid Imagination 28G remained a top-selling dried flower SKU, while the launch of Chemzilla 14G supported flower portfolio diversification and product mix optimization. The Fire Breath cultivar, originally launched in late 2024 in Quebec and Ontario, has expanded distribution in British Columbia, Nova Scotia and PEI, aligning with our national growth strategy. The Company has continued to strengthen its position in the value segment through the expansion of milled flower offerings. The Company continues to defend its leadership position in the competitive vape category. During the quarter, the Company launched a new flavor within the Back Forty all-in-one vape line-up, which quickly became a top-selling SKU. This strong consumer uptake reflects the brand equity that the Company has built in the category, as consumers were eager to trial the new flavor offering. In the pre-roll category, the Company refreshed its product portfolio led by the successful launch of Lemon Diesel and Pine Tar Kush which drove incremental volumes.
Gross margin on finished cannabis inventory sold improved to 48% in the quarter, compared to 38% in the same period of 2024, driven by higher cultivation yields, improved product pricing in the adult-use market, and a refined customer mix. SG&A expenses were $9.7 million, a 12% increase year-over-year, primarily reflecting strategic investments to support higher sales volumes, build brand equity, expand distribution networks, and deepen retail relationships — critical barriers to entry in a competitive market.
Auxly remains committed to strengthening its balance sheet. During the quarter, the Company continued to reduce its debt and remained actively engaged with its creditors to manage liabilities and ensure working capital flexibility to fund future growth initiatives.
The Company remains confident in its ability to deliver sustainable, profitable growth through a focus on innovation, operational excellence, and disciplined execution. By advancing its strategic priorities, Auxly aims to reinforce its leadership in the Canadian cannabis market, build a strong foundation for future global opportunities, and create long-term value for all stakeholders.
Non- GAAP Measures
Please see the Company's MD&A dated May 14, 2025, under "Non-GAAP Measures" for a further description of the following financial and supplementary financial measures.
Financial Measures
These are non-GAAP measures used in the cannabis industry and by the Company to assess operating performance removing the impacts and volatility of non-cash and other adjustments. The definition may differ by issuer. The Adjusted EBITDA reconciliation is as follows:
(000's)
Q2/23
Q3/23
Q4/23
Q1/24
Q2/24
Q3/24
Q4/24
Q1/25
Net income/(loss)
$ (12,863)
$ 32,621
$ (54,020)
$(26,012)
$ 2,002
$ 3,239
$ 4,423
$12,111
Interest and accretion expense
6,457
6,613
6,837
6,868
2,749
3,133
2,291
2,147
Interest and other income
20
(16)
(22)
(19)
(140)
(54)
(27)
(47)
Income tax expense/(recovery)
-
-
(3,238)
15,992
-
-
-
(8,125)
Depreciation and amortization
included in cost of sales
911
1,151
1,084
1,292
1,780
1,382
1,338
1,274
Depreciation and amortization
included in expenses
1,673
1,817
1,708
1,230
1,067
1,197
990
1,296
EBITDA
(3,802)
42,186
(47,651)
(649)
7,458
8,897
9,015
8,656
Impairment of inventory
1,459
3,233
5,109
456
473
674
729
123
Unrealized fair value loss/(gain) on biological transformation
(4,713)
(4,766)
(2,481)
(2,773)
(8,817)
(9,964)
(11,073)
(12,312)
Realized fair value loss/(gain) on inventory
3,146
5,538
5,428
2,435
4,464
7,703
11,625
9,337
Restructuring and acquisition costs
86
29
131
-
655
(75)
271
-
Equity-based compensation
377
707
148
1,927
701
1,324
1,103
1,505
Impairment of assets
2,588
-
37,118
-
-
-
-
-
Non-recurring bad debt expense/(recovery)
780
360
-
-
-
(123)
-
-
(Gain)/loss on settlement of assets, liabilities and disposals
(1,478)
(46,887)
4,006
634
62
(183)
(1,461)
(39)
Foreign exchange loss/(gain)
479
(283)
486
210
177
33
797
163
Adjusted EBITDA
$ (1,078)
$ 117
$ 2,294
$ 2,240
$ 5,173
$ 8,286
$ 11,006
$ 7,433
Supplementary Financial Measures
Gross Margin on Finished Cannabis Inventory Sold
"Gross Margin on Finished Cannabis Inventory Sold" is a supplementary financial measure and is defined as net revenues less cost of finished cannabis inventory sold divided by net revenues.
Gross Profit Margin
"Gross Profit Margin" is defined as gross profit divided by net revenues. Gross Profit Margin is a supplementary financial measure.
Debt
"Debt" is defined as current and long-term debt and is a supplementary financial measure. It is a useful measure in managing the Company's capital structure and financing requirements.
ON BEHALF OF THE BOARD
"Hugo Alves" CEO
About Auxly Cannabis Group Inc. (TSX: XLY)
Auxly is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto, Canada. Our mission is to help consumers live happier lives through quality cannabis products that they trust and love.
Our vision is to be a leader in branded cannabis products that deliver on our consumer promise of quality, safety and efficacy.
Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.
Notice Regarding Forward Looking Information:
This news release contains certain "forward‐looking information" within the meaning of applicable Canadian securities law. Forward‐looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward‐looking information throughout this news release. Forward‐looking information includes, but is not limited to: the proposed operation of Auxly, its subsidiaries and partners; the intention to grow the business, operations and existing and potential activities of Auxly; proposed timelines for the build‐out, expansion, licencing or commercialization of the Company's facilities and projects; the Company's execution of its innovative product development, commercialization strategy and expansion plans; the Company's intention to introduce innovative new cannabis products to the market and the timing thereof; the anticipated benefits of the Company's partnerships, research and development initiatives and other commercial arrangements; the expectation, timing and quantum of future revenues, Gross Margin on Finished Cannabis Inventory Sold, SG&A and of positive Adjusted EBITDA; expectations regarding the Company's expansion of sales, operations and investment into foreign jurisdictions; future legislative and regulatory developments involving cannabis and cannabis products; the timing and outcomes of regulatory or intellectual property decisions; the ability of the Company to maintain and grow its market share; the relevance of Auxly's subsidiaries' current and proposed products with provincial purchasers and consumers; consumer preferences; political change; competition and other risks affecting the Company in particular and the cannabis industry generally.
A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward‐looking information in this release including, but not limited to, whether: the Company will be able to execute on its business strategy or achieve its goals; Auxly's subsidiaries are able to maintain the necessary governmental and regulatory authorizations to conduct business; the Company is able to successfully manage the integration of its various business units with its own; the Company's subsidiaries obtain and maintain all necessary governmental and regulatory permits and approvals for the operation of their facilities and the development of cannabis products, and whether such permits and approvals can be obtained in a timely manner; the Company will be able to successfully launch new product formats and enter into new markets; there is acceptance and demand for current and future Company products by consumers and provincial purchasers; the Company will be able to increase and maintain revenues, maintain positive Adjusted EBITDA, and/or achieve and maintain its target Gross Margin on Finished Cannabis Inventory Sold; risks relating to the overall macroeconomic environment, which may impact customer spending, the Company's costs and margins, including tariffs (and related retaliatory measures), the levels of inflation, and interest rates; and general economic, financial market, legislative, regulatory, competitive and political conditions in which the Company and its subsidiaries and partners operate will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2024 dated March 20, 2025.
New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward‐looking information. The forward‐looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward‐ looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward‐looking information attributed to third party industry sources, the accuracy of which has not been verified by the Company. The forward‐looking information is being provided for the purposes of assisting the reader in understanding the Company's financial performance, financial position and cash flows as at and for periods ended on certain dates and to present information about management's current expectations and plans relating to the future, and the reader is cautioned that such forward‐ looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward‐looking information contained in this release.
The forward‐looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward‐ looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.
SOURCE Auxly Cannabis Group Inc.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Frontera Energy Provides Notice of Second Quarter 2025 Financial Results Conference Call
CALGARY, AB, July 24, 2025 /CNW/ - Frontera Energy Corporation (TSX: FEC) (" Frontera" or the " Company") announces that the Company will release its financial and operational results for the second quarter ended June 30, 2025, after markets close on Wednesday, August 13th, 2025.
Cision Canada
an hour ago
- Cision Canada
Frontera Energy Provides Notice of Second Quarter 2025 Financial Results Conference Call
CALGARY, AB, July 24, 2025 /CNW/ - Frontera Energy Corporation (TSX: FEC) (" Frontera" or the " Company") announces that the Company will release its financial and operational results for the second quarter ended June 30, 2025, after markets close on Wednesday, August 13th, 2025. A conference call for investors and analysts will be held on Thursday, August 14th, 2025, at 11:00 p.m. Eastern Time. Participants will include Gabriel de Alba, Chairman of the Board of Directors, Orlando Cabrales, Chief Executive Officer, René Burgos, Chief Financial Officer, and other members of the senior management team. Analysts and investors are invited to participate using the following dial-in numbers: A replay of the conference call will be available until 11:59 p.m. Eastern Time on August 21st, 2025. About Frontera: Frontera Energy Corporation is a Canadian public company involved in the exploration, development, production, transportation, storage and sale of oil and natural gas in South America, including related investments in both upstream and midstream facilities. The Company has a diversified portfolio of assets with interests in 22 exploration and production blocks in Colombia, Ecuador and Guyana, and pipeline and port facilities in Colombia. Frontera is committed to conducting business safely and in a socially, environmentally and ethically responsible manner.
Globe and Mail
an hour ago
- Globe and Mail
Imperial Provides Update on Fall of Ground Incident and Reports Production for 2025 Second Quarter at Red Chris Mine
VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation ('Imperial' or the 'Company') (TSX:III) provides an update on the two fall of ground incidents at the 30% owned Red Chris mine in northwest British Columbia. In coordination with industry partners, mine operator Newmont has deployed specialized drones to assess the geotechnical conditions underground. The debris blocking access to the underground area is estimated to be approximately 20 to 30 metres long and 7 to 8 metres high. The area of the refuge chambers is not in the same area as the fall of ground and is understood to be stable and well-ventilated. Newmont has commenced the use of a remote-controlled scoop, that was transported from the nearby Brucejack mine site, to begin removing debris and restore access beyond the incident site. Teams are restoring the specialized communication system (leaky feeder system) in attempts to re-establish communication with the workers. The workers are understood to be sheltering in a MineARC refuge chamber designed to support 16 people. Additional refuge chambers are also available nearby and accessible if required. Production at Red Chris mine has been paused to allow full focus on rescue efforts and re-establishing communication. Imperial also reports quarterly copper and gold production for the period ending June 30, 2025 from Red Chris mine. Red Chris mine production (100%) for the second quarter of 2025 was 23.479 million pounds copper and 22,624 ounces gold compared to 20.731 million pounds copper and 12,531 ounces gold during the second quarter of 2024. In the second quarter of 2025, Red Chris mine copper production was up 13% compared to the second quarter of 2024. The increase in copper production was a result of a 17% increase in copper grade (0.547% vs 0.466%), offset by a small decrease in throughput. Gold production in the second quarter of 2025 was up 81% from the second quarter of 2024 as result of the increased gold grades and better recovery, offset by slightly lower throughput. For the first six months of 2025, copper production was up 25% compared to the same period last year on higher copper grades and gold production was up 101% on higher gold grades and better recovery. 100% Red Chris mine production Three Months Ended June 30 Six Months Ended June 30 2025 2024 2025 2024 Ore milled - tonnes 2,393,788 2,489,532 4,443,263 4,589,886 Ore milled per calendar day – tonnes 26,305 27,357 24,414 25,219 Grade % - copper 0.547 0.466 0.580 0.450 Grade g/t – gold 0.490 0.302 0.514 0.284 Recovery % - copper 81.4 81.1 82.0 82.1 Recovery % - gold 60.0 51.8 60.3 52.6 Copper - 000's pounds 23,479 20,731 46,606 37,392 Gold – ounces 22,624 12,531 44,287 22,038 The Red Chris Block Cave Feasibility Study is advancing as are permitting activities and early-stage underground development work and other work to support the underground block cave project. The total development completed to June 30, 2025, was approximately 11,727 metres, completed on both the Nagha and conveyor declines. The technical and scientific information related to the Company's mineral projects has been reviewed and approved by Brian Kynoch, President of Imperial, the designated Qualified Person as defined by National Instrument 43-101. About Imperial Imperial is a Vancouver based exploration, mine development and operating company with holdings that include the Mount Polley mine (100%), the Huckleberry mine (100%), and the Red Chris mine (30%). Imperial also holds a portfolio of 23 exploration properties in British Columbia. Company Contacts Brian Kynoch | President | 604.669.8959 Darb S. Dhillon | Chief Financial Officer | 604.669.8959 Cautionary Note Regarding Forward-Looking Statements Certain information contained in this news release are not statements of historical fact and are 'forward-looking' statements. Forward-looking statements relate to future events or future performance and reflect Imperial management's expectations or beliefs regarding future events and include, but are not limited to, statements regarding the ongoing work to advance the Red Chris Block Cave Feasibility Study, permitting activities and early-stage underground development work and other work to support the underground block cave project. In certain cases, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "outlook", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative of these terms or comparable terminology. By their very nature forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Imperial to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. In making the forward-looking statements in this news release, Imperial has applied certain factors and assumptions that are based on information currently available to Imperial as well as Imperial's current beliefs and assumptions. These factors and assumptions and beliefs and assumptions include, the risk factors detailed in Imperial's current annual information form and from time to time in Imperial's interim and annual financial statements and management's discussion and analysis of those statements, all of which are filed and available for review on SEDAR+ at Although Imperial has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended, many of which are beyond Imperial's ability to control or predict. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and all forward-looking statements in this news release are qualified by these cautionary statements.
